The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...

Novo Nordisk fell more than 4% on Friday to their lowest level since Aug. 10 after the Danish drugmaker reported results from ...

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...

The results jibe with earlier research showing that childhood obesity rates are steadily rising, even though food insecurity ...

Control of multiple risk factors "effectively nullified” the excess risk for chronic kidney disease in individuals with ...

Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...

Research in people with obesity or overweight has shown that long-term exercisers have belly fat with healthier properties ...

About 40% of Louisiana adults are obese, according to new data released by the Centers for Disease Control and Prevention.

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...